Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share

Article Stock Quotes (1) Comments (0)

Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $931 thousand versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
• NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
• Pacific Sunwear Of California (PSUN) Tops Q1 EPS by 5c, Offers Guidance

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?